$PLNeutralMed

Planet Labs (PL) To Report Earnings Tomorrow: Here Is What To Expect

Planet Labs (NYSE: PL) will report earnings Thursday after market close, according to the article. Last quarter, it reported revenue of $86.82 million, up 41.1% year on year, and beat analysts’ revenue and EPS estimates. For the upcoming quarter, analysts expect revenue growth of 36.2% y/y. The article cites an average analyst price target of $35.50 versus a $48.20 current share price.

9/10
4/10
Med
Neutral
Ahead of Planet Labs’ after-market earnings report this Thursday.
Moderately constructive: stock up 25.1% over the month and analysts reconfirm estimates, but credibility risk remains due to prior revenue misses.

Pre-earnings positioning focus: consensus revenue growth is much higher than last year, but the stock has missed revenue estimates multiple times.

Planet Labs is scheduled to report earnings after the close, with the article citing revenue/EPS expectations and recent estimate revisions.

Elevated volatility expected into the after-hours print; direction likely hinges on whether revenue growth and any EPS beat/guide match the raised expectations.

Background

Planet Labs beat revenue/EPS last quarter and is entering this quarter with analysts reconfirming estimates over the prior 30 days.

Why it matters

Key trading question is whether the company can sustain the expected 36.2% YoY revenue growth and avoid another revenue miss, given the stock’s prior pattern.

Market relevance

Earnings catalyst with consensus revenue growth acceleration and a noted history of revenue misses; recent price strength may increase sensitivity to any shortfall.

Market effects

Read-through to data/business process services and satellite/earth-imaging demand expectations, though the article is primarily single-name earnings-focused.

Limited; the story is US-listed earnings with no specific regional macro linkage.

Low; no new global policy/contract details—only earnings timing and consensus framing.

Alternative perspectives

Despite the stock’s strong run-up and reconfirmed estimates, repeated revenue-estimate misses raise the odds that expectations are still fragile.

The article doesn’t include guidance details, margin/cash-flow trends, or backlog/contract specifics—items that often dominate satellite-earnings reactions.

Key entities

  • Planet Labs

    Earth imaging satellite company reporting earnings after the close this Thursday.

  • Fair Isaac Corporation

    Peer referenced for reported results and post-earnings reaction.

  • CoStar

    Peer referenced for reported results and post-earnings reaction.

Related articles

$PLMedAI 9/10

Planet Labs Posts Record Quarterly Revenue, Stock Slides Anyway - Planet Labs (NYSE:PL)

Planet Labs reported Q1 adjusted loss of 3 cents per share, better than the 4-cent consensus, and revenue of $94.15 million, above the $89.85 million estimate and up 42% year over year. Remaining performance obligations rose to $816 million and backlog to $906+ million. The company raised FY2027 revenue guidance to $425–$441 million. Shares were down about 7.6% to $40.22.

$PLMedAI 9/10

Planet Labs Q1 Loss Widens, But Revenue Jumps 42%

Planet Labs PBC reported a wider Q1 net loss of $138.9 million ($0.40/share) versus a $12.6 million loss ($0.04/share) a year earlier, largely due to a one-time non-cash $106.5 million charge from revaluing warrant liabilities. Revenue rose 42% to $94.2 million. Adjusted loss was $8.8 million ($0.03/share). The company forecast Q2 revenue of $102–$107 million and FY2027 revenue of $425–$441 million.

$RKLBMed

RKLB, LUNR, SPCE, and Planet Labs May Crash Ahead of SpaceX IPO

Space stocks have surged this year on expectations for a SpaceX IPO that could value the company above $1.7 trillion, with Polymarket traders projecting over $2 trillion. The Procure Space ETF (UFO) is up 146% in 12 months; Rocket Lab (RKLB) is up 382% to a $83B market cap. The article warns of a “buy the rumor, sell the news” pullback and high valuations (Planet Labs forward P/S 51; RKLB 91).

$SPCEMedAI 9/10

Virgin Galactic Crashes 32% on Settlement Dilution Fears, AST SpaceMobile Rises 10%, Planet Labs Climbs 9%

Virgin Galactic (SPCE) fell about 32% after preliminary court approval for a shareholder derivative settlement revived dilution concerns tied to its capital realignment plan, which included debt restructuring and new share issuance. AST SpaceMobile (ASTS) rose about 10% after reaffirming FY2026 revenue guidance of $150M–$200M and confirming three Falcon 9 launches in mid-June. Planet Labs (PL) gained about 9% on quarterly revenue of $81.25M (+33% YoY) and higher remaining performance obligations